Q4 2024 Aptargroup Inc Earnings Call Transcript
Key Points
- AptarGroup Inc (ATR) achieved core sales growth of 2% in the fourth quarter, exceeding the top end of their guidance range.
- The pharma segment achieved 8% core sales growth for the year, driven by increased sales of higher value products and royalties.
- The company reported an adjusted EBITDA margin of 23% for the fourth quarter, at the top end of their long-term range.
- AptarGroup Inc (ATR) returned nearly $800 million to shareholders over the last five years through dividends and share repurchases.
- The company was recognized on the Climate A-List by CDP for leadership in corporate sustainability and environmental transparency.
- The beauty segment experienced a decline in core sales due to an unfavorable mix, despite growth in personal care technologies.
- The company anticipates a significant currency headwind and higher effective tax rate impacting first quarter results.
- Consumer healthcare core sales decreased by 17% due to decreased demand for nasal decongestants and other products.
- The beauty segment's adjusted EBITDA margin declined by 230 basis points due to lower sales of higher value prestige products.
- AptarGroup Inc (ATR) faces challenges in the Chinese market, with local brands gaining share over multinationals.
Ladies and gentlemen, thank you for standing by. Welcome to Aptar 2024 fourth quarter and annual results conference call. (Operator Instructions)
Introducing today's conference call is Mrs. Mary Skafidas, Senior Vice President, Investor Relations and Communications. Please go ahead.
Good morning. Hello everyone and thanks for being with us today. Joining us on today's call are Stephan Tanda, President and CFO; and Vanessa Kanu, Executive Vice President and CFO. Our press release and accompanying slide deck have been posted on our website under the investor relations page.
During this call we will be discussing certain non-GAAP financial measures. These measures are reconciled to the most directly comparable GAAP financial measure and the reconciliations are set forth in the press release. Please refer to the press release disseminated yesterday for reconciliations of non-GAAP measures to the most comparable GAAP measures discussed during the earnings
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |


